Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension

Blood Pressure

Volumn 16, Issue SUPPL. 2, 2007, Pages 25-30

  Nilsson, Peter ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

atenolol; blood pressure; control rate; First line therapy; hypertension; zofenopril

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; ZOFENOPRIL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATENOLOL; BLOOD PRESSURE; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 74249117410     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08038020701561745     Document Type: Article

References (19)

1. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Blood Press. 2007;16:135-232.
2. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA. 1998;279:1903-1907. (Pubitemid 28299288)
3. Messerli FH, Grossman E. Beta-blockers and diuretics: To use or not to use. Am J Hypertens. 1999;12:157S-163S.
4. Messerli FH, Beevers DG, Franklin SS, Pickering TG. Betablockers in hypertension - The emperor has no clothes: An open letter to present and prospective drafters of new guidelines for the treatment of hypertension. Am J Hypertens. 2003;16:870-873. (Pubitemid 37204686)
5. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens. 2006;24:3-10. (Pubitemid 41819128)
6. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. for the Captopril Prevention Project (CAPPP) study group. Effect of angiotensin-convertingenzyme inhibitor compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999;353:611-616. (Pubitemid 29087980)
7. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
8. Dahlöf B, Sever PS, Poulter NR, for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366:895-906. (Pubitemid 41265663)
9. Lacourcière Y, Provencher P. Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Br J Clin Pharmacol. 1989;27:371-376. (Pubitemid 19097449)
10. Borghi C, Ambrosioni E. Zofenopril: A review of the evidence of its benefits in hypertension and acute myocardial infarction. Clin Drug Invest. 2000;20:371-384.
11. Narkiewicz K. Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan. Blood Press. 2007;16 Suppl:7-12.
12. Mallion J-M. An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. Blood Press. 2007;16 Suppl:13-18.
13. Farsang C. Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients. Blood Press. 2007;16 Suppl:19-24.
14. Turnbull F. Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different blood pressurelowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials. Lancet. 2003;362:1527-1535. (Pubitemid 37410190)
15. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med. 2005;165:1410-1419. (Pubitemid 40973424)
16. Malacco E, Castiglioni G, Corradi L, Cristofari M, Fogari R, Pisani A, et al. Dose-response relationship of zofenopril in essential hypertension: A 24-hour blood pressure-monitoring study. Clin Drug Invest. 2002;22:9-15. (Pubitemid 34151328)
17. Zanchetti A, Parati G, Malacco E. Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. Review article. Drugs. 2006;66:1107-1115. (Pubitemid 43945870)
18. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545-1553. (Pubitemid 41540112)
19. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: Is it awise choice? Lancet. 2004;364:1684-1689.